Antibiotics Market Size, Share & Trends Analysis Report By Product

The Business Research Company’s Antibiotics Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034

LONDON, GREATER LONDON, UNITED KINGDOM, November 24, 2025 /EINPresswire.com/ -- What Is The Antibiotics Market Size And Growth?
The size of the antibiotics market has seen a consistent increase in the past few years. The market, valued at $85.14 billion in 2024, is projected to reach $89.16 billion in 2025, growing at a compound annual growth rate (CAGR) of 4.7%. This growth during the historical period is due to factors such as an increase in infectious diseases, population growth and urbanization, heightened awareness about healthcare, improved access to healthcare services, and the prevalence of antibiotic-resistant strains.

In the upcoming years, the antibiotics market is anticipated to experience robust expansion, with its value expected to reach ""$109.51 billion by 2029, growing at a compound annual growth rate (CAGR) of 5.3%. This growth during the forecasted period is driven by global health challenges, escalating healthcare costs, governmental programs and regulations, and amplified international cooperation. Key trends in the forecast period encompass the evolution of oral antibiotics, cooperation and alliances for antibiotic progress, regulatory incentives and pathways, antimicrobial stewardship initiatives in healthcare, and worldwide health initiatives for access to antibiotics.

Download a free sample of the antibiotics market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11923&type=smp

What Are The Current Leading Growth Drivers For Antibiotics Market?
The antibiotics market is anticipated to be propelled by the increasing incidents of bacterial infections. These infections are triggered by bacteria, single-celled organisms that are minuscule in size. The growth of these bacteria is hindered by antibiotics, making them extremely valuable in preventing and treating bacterial diseases. For instance, as of February 2023, the World Health Organization, an American-based specialized health agency located in Switzerland, reported that in 2022, 30 countries globally were grappling with a cholera outbreak. The cholera case fatality ratio (CFR) stood at 1.9% in 2021, marking the peak in a decade. Consequently, the surge in bacterial infections is fuelling the antibiotics market.

Which Companies Are Currently Leading In The Antibiotics Market?
Major players in the Antibiotics include:
• Pfizer Inc.
• Johnson & Johnson
• F. Hoffmann-La Roche AG
• Merck & Co Inc.
• AbbVie Inc.
• Bayer AG
• Novartis AG
• Sanofi SA
• Bristol Myers Squibb (BMS)
• AstraZeneca plc

What Are The Main Trends, Positively Impacting The Growth Of Antibiotics Market?
A significant shift in the antibiotics market is attributable to the approval of new products, with major firms obtaining regulatory permissions for innovative antibiotic formulations. For instance, Alkem Laboratories Ltd., a pharmaceutical firm based in India, launched Zidavi in January 2023. The medication, a blend of ceftazidime and avibactam, is used to treat complicated illnesses like urinary tract infections, intra-abdominal infections, and pneumonia resulted from multi-drug resistant (MDR) Gram-negative bacteria. Zidavi, being one of the scarce antibiotics effective against MDR Gram-negative bacteria, represents a crucial step forward in the battle against antibiotic resistance.

How Is The Antibiotics Market Segmented?
The antibiotics market covered in this report is segmented –
1) By Drug Class: Penicillin, Cephalosporin, Aminoglycosides, Tetracycline, Macrolides, Fluoroquinolones, Sulfonamides, Other Classes
2) By Spectrum Of Activity: Broad-spectrum Antibiotic, Narrow-spectrum Antibiotic
3) By Route Of Administration: Oral, Intravenous, Other Routes
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
5) By Application: Skin Infections, Respiratory Infections, Urinary Tract Infections, Septicemia, Ear Infections, Gastrointestinal Infections, Other Applications

Subsegments:
1) By Penicillin: Natural Penicillins, Aminopenicillins, Penicillinase-resistant Penicillins, Extended-spectrum Penicillins
2) By Cephalosporin: First-generation, Second-generation, Third-generation, Fourth-generation, Fifth-generation
3) By Aminoglycosides: Gentamicin, Tobramycin, Amikacin, Neomycin
4) By Tetracycline: Tetracycline, Doxycycline, Minocycline, Oxytetracycline
5) By Macrolides: Erythromycin, Azithromycin, Clarithromycin
6) By Fluoroquinolones: Ciprofloxacin, Levofloxacin, Moxifloxacin, Ofloxacin
7) By Sulfonamides: Sulfamethoxazole, Sulfadiazine, Sulfasalazine
8) By Other Classes: Glycopeptides, Lipopeptides, Streptogramins, Polymyxins

View the full antibiotics market report:
https://www.thebusinessresearchcompany.com/report/antibiotics-global-market-report

Which Is The Dominating Region For The Antibiotics Market?
In 2024, North America dominated the antibiotics market. It is projected that Asia-Pacific region will experience the fastest growth in the forecasted period. The report on the antibiotics market focuses on numerous regions which include North America, Asia-Pacific, Western Europe, Eastern Europe, South America, Middle East and Africa.

Browse Through More Reports Similar to the Global Antibiotics Market 2025, By The Business Research Company
Gastrointestinal Drug Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/gastrointestinal-drug-global-market-report

Nutritional Feed Additives Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/nutritional-feed-additives-global-market-report

Pharmacies And Drug Stores Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/pharmacies-and-drug-stores-global-market-report

Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: saumyas@tbrc.info
The Business Research Company - www.thebusinessresearchcompany.com

Follow Us On:
• LinkedIn: https://in.linkedin.com/company/the-business-research-company

Oliver Guirdham
The Business Research Company
+44 7882 955267
info@tbrc.info
Visit us on social media:
LinkedIn
Facebook
X